Ozempic Reshapes The Kinds of Food People Eat. Here's What Happens.
We've heard how the use of drugs like Ozempic can drive weight loss, as well as potentially boost heart health and cut out alcohol cravings; now a new study reveals fresh insights into how the medication can change eating habits, too.
Along with other semaglutide drugs like Mounjaro and Wegovy, Ozempic is what's known as a glucagon-like peptide-1 receptor agonist (GLP-1RA), which means it mimics the body's natural response to food to reduce appetite and slow digestion.
Led by the US Department of Agricultural Economics & Agribusiness, the study analyzed the eating habits of 1,955 participants, split into four groups: those currently taking GLP-1RAs, those who had taken them in the past, those who were planning to take them, and those who had never taken them and weren't planning to.
"Results show that consumers currently taking a GLP-1RA consume significantly fewer calories than the other groups surveyed, and calorie reduction while taking a GLP-1RA for weight loss could be around 720 to 990 calories," write the researchers in their published paper.
As well as cutting down on the calories, those taking GLP-1RAs were most likely to reduce the amount of processed foods, sugary drinks, refined grains (such as white bread), and beef in their diet. Consumption of fruits, leafy greens, and water all went up, however.
There was a twist in the data story: people taking GLP-1RAs reported that they still wanted to eat high-calorie foods like processed foods and sugary drinks as much as before, they just chose not to, for whatever reason. Those effects could be the subject of future studies, the researchers suggest.
With tens of thousands of people starting a course of a GLP-1RA drug every week in the US, this shift in eating habits could have a major impact on food and drink production. We might even see foods specifically marketed towards people taking these drugs.
"Our study shows that adoption of GLP-1 agonists changes both the amount and types of food people eat," says agricultural economist Jayson Lusk of Oklahoma State University.
"These results have important implications for the food industry."
It's worth bearing in mind that Ozempic and drugs like it are still relatively new, and there's still a lot more to discover about them and how they work, beyond the average 15-20 percent weight loss they can lead to.
Originally developed to treat diabetes, these drugs are not without their side effects, and can trigger digestive problems in some people. One of the ways in which this new research might help is by pointing to dietary routines that could help boost the positives of GLP-1RAs while minimizing the risks.
"These findings underscore the need for further research into the specific physiological and metabolic pathways affected by GLP-1RAs, particularly regarding how they reshape dietary behaviors," write the researchers.
The research has been published in Food Quality and Preference.
'Landmark Moment': New Breast Cancer Treatment Approved in UK
Researchers Identify New Blood Group After 50 Year Mystery
Screen Time In Bed May Increase Insomnia Odds, Study Suggests
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Mama June Praises The Benefits Of Weight Loss Shots After Quitting It
Mama June is in her healthy era! The reality star is choosing to live a healthy life, and the process has been rewarding, as she has now discontinued her weight loss medications. Mama June's struggle with weight management has been a central point in her life for years. She previously went under the knife for weight loss surgery in 2016. The TV star recently shared exciting news about her health journey, revealing she has stopped using weight loss medication. Mama June confirmed that she has not relied on weight loss shots since December and has successfully maintained her weight through lifestyle changes. She highlighted the benefits of weight loss shots, particularly for individuals managing medical conditions. "I tell you all the time, if you choose to go on the weight loss shot, it has so many benefits. Not just for weight loss, but for, like, people who have like PCOS, women's issues, people who have inflammation, people who have other issues going on," she said. The reality star began her weight loss journey with injections in April 2024, eight years after undergoing weight loss surgery in 2016, which helped her reach a weight of 195 pounds. However, she struggled to maintain her weight as she faced challenges during her eldest daughter Anna Cardwell's cancer battle. Mama June was even more overwhelmed when her efforts to salvage Anna's life did not yield, and she unfortunately passed at the age of 29 in December 2023. In June 2024, June opened up about taking medications for her weight loss. In her words: "I've been on weight loss medication. I was first on Semaglutide, which is like Ozempic. And now I'm on Triglycerides for the last three weeks." She also claimed the medications were super helpful at the time, with zero side effects to threaten her health. Today, In Touch confirmed that she appears to be focusing on her health sustainably, celebrating her progress while promoting the new season of "Mama June: Family Crisis." In her revelation last year, she added that she also kept the weight off by exercising "three or four times a week." She reflected on her past experiences with gastric procedures, expressing her initial aversion to the potential side effects like nausea and vomiting. However, she noted that since starting her new medication, she has experienced no adverse effects and has avoided sweets and sodas. June mentioned that while diabetes medications are often associated with lowering blood sugar, she has had no issues in that area since beginning treatment. She spotted the difference in weight loss rates between her previous surgery and the medication. According to her: "I've just been really good and consistent. The only difference [for] this medicine and the gastric sleeve is I lost 160 pounds in four weeks [with the surgery] and with this I lose four pounds a week." The reality star has documented her weight loss on social media, sharing that as of September 2024, she had lost a total of 60 pounds. Since Anna's passing, a whole lot has changed for Mama June and her family. Her last daughter, Alana, now 19, has relocated to Colorado to pursue a degree in nursing. Alana became popular on TV following her appearance on TLC's "Toddlers & Tiaras." She quickly became a reality TV sensation with her confident catchphrase, "Honey Boo Boo Child!" Along with her entertaining family, she starred in a series of shows and specials that instantly brought her fame. Reflecting on her rise to stardom, Alana expressed her bewilderment over how she came up with her iconic phrase, stating, "To this day, I still cannot tell you what I thought when I was saying 'Honey Boo Boo Child.'" Now that she has moved to Georgia, which she had always known as home, Alana admits, "Absolutely, no. I do not miss Georgia. I don't miss a thing about Georgia," though she acknowledges missing the people she left behind. With a sense of humor about her past as a reality star, she noted that she might still be known as 'Honey Boo Boo' even at 60, joking about being approached for photos in a nursing home. Anna's battle with cancer has also intensified Alana's desire to help others. She was deeply affected by the care Anna received and the positive impact of her nurses, which inspired Alana to pursue a career in nursing. As shared by TODAY, she expressed her aspiration to be a supportive nurse, reflecting her commitment to helping others in times of need. Last year, The Blast shared that Mama June opened up about the profound emptiness left by her daughter Anna Cardwell's passing. She shared the challenging reality her family has faced since losing Anna, detailing the impact on her granddaughters, 12-year-old Kaitlyn and 8-year-old Kylee. The loss has been especially difficult for the girls, with Mama June noting the significant struggles they have had to endure. In addition to dealing with the grief, Mama June has navigated a complicated custody situation. Following Anna's death, she fought and won a custody battle for Kaitlyn against her former son-in-law, Michael Cardwell. This battle was worsened by Michael's move to Alabama, which disrupted their family arrangement. Mama June decided to stay in Georgia despite her plans to relocate to prevent Kylee from moving away. Despite the daunting situation, Mama June shared her commitment to keeping Anna's husband, Eldridge Toney, involved in the lives of her granddaughters, honoring Anna's wishes in the process. Things got heated during the custody battle with Michael. While Anna's former husband claimed Anna and Mama June were not on good terms before her death, the reality star set the record straight. According to Mama June, Michael was the abusive one during his marriage to her late daughter. She claimed Michael constantly abused Anna and Kaitlyn. The court eventually ruled that Mama June would retain Kaitlyn's legal and physical custody. The court also placed restrictions on Michael, prohibiting him from contacting Mama June or Kaitlyn unless they both agreed to a visitation arrangement. Kaitlyn, who has been residing with her grandmother since Anna's battle with cancer, had previously expressed her strong desire to stay with Mama June during testimony in court. Big ups to Mama June for doing the best for her wellness despite what life is throwing at her.
Yahoo
14 hours ago
- Yahoo
Vantive to invest $1bn for kidney care advancement
Vantive is investing $1bn towards advancing its kidney care and vital organ support proposition. The company, which was formerly Baxter's kidney care unit, becoming Vantive after being spun out as part of a $3.5bn divestment deal with global investment firm Carlyle in 2024, stated that the investment would be allocated over a five-year period and have a particular focus on advancing R&D and manufacturing capacity. According to Vantive, hastening the course of innovation is critical in order to meet the demand presented by the increasing burden of chronic kidney disease (CKD) end-stage renal disease (ESRD) – which research indicates places an annual healthcare burden on Europe of around $140bn annually. In addition, there is a pressing need for acute organ support therapy options, with research indicating that 60% of patients in the intensive care unit (ICU) may have acute kidney injury. Through the development of digitally enabled dialysis and critical care products and services, the company said it aims to power earlier and better-informed clinical decision-making, minimise disruption of care for patients and clinical teams, shift kidney care management from episodic to proactive, and enhance patient-care team connectivity. In turn, Vantive also plans to build a 'stronger' foundation for digital support, with plans to develop existing products including its virtual reality (VR) training on-demand for clinicians using Vantive's therapies, and its remote patient management platform. Ahead of the European Renal Association (ERA) conference where further details are set to be announced, Vantive CEO Chris Toth said the funding underscored its commitment to 'shaping the future of kidney care and vital organ support'. 'Better outcomes are possible when care is more accessible, more intuitive, and more connected to the needs of patients as well as the realities of the modern healthcare ecosystem. 'That's why we are focused on transforming where and how therapy is delivered – from life-saving critical care for patients in a hospital, to life-sustaining dialysis for patients at home.' CKD is a metabolic disorder related to conditions such as diabetes, for Glucagon-like peptide-1 receptor agonists (GLP-1Rs) have shown promise. Due to their potentially wider therapeutic benefits, GLP-1R could potentially transform treatment paradigms of multiple chronic diseases, as per GlobalData analysis. "Vantive to invest $1bn for kidney care advancement " was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
New York Post
14 hours ago
- New York Post
AI could ‘devastate' Earth's population down to the size of the UK by 2300, expert warns: ‘People really don't have a clue'
Are we facing tech-stinction? An Oklahoma tech expert predicted that artificial intelligence will become so omnipresent on the planet that Earth — with a current estimated population of about 8 billion — will have just 100 million people left by the year 2300. 'It's going to be devastating for society and world society,' Subhash Kak, who teaches computer science at Oklahoma State University in Stillwater, Oklahoma, told the Sun. 'I think people really don't have a clue.' Advertisement However, the 'Age of Artificial Intelligence' author doesn't think this dystopian future will come about via nuclear war or other 'Terminator'-evoking scenarios, but rather through replacing our jobs. 3 This dystopian scene from 2009's 'Terminator Salvation' could have a basis in reality. 'There are demographers who are suggesting that as a consequence, the world population will collapse and it could go down to as low as just 100 million people on the entire planet Earth in 2300 or 2380,' Kak warned. Warner Bros/Courtesy Everett Collection 'Computers or robots will never be conscious, but they will be doing literally all that we do because most of what we do in our lives can be replaced,' said Kak. Advertisement Currently, techsperts fear that AI is rendering humanity obsolete in every sector, from law to academia and even romance. As a result, they suggest, birth rates will plunge as people will be hesitant to have kids who are destined to be unemployed, especially given the exorbitant costs of rearing children. 3 The professor feared people wouldn't want to have children who are destined to be unemployed. AFP via Getty Images Without people making babies, the global population will suffer an apocalyptic blow, Kak theorized. Advertisement 'There are demographers who are suggesting that as a consequence, the world population will collapse, and it could go down to as low as just 100 million people on the entire planet Earth in 2300 or 2380,' he warned of the shocking drop. With only that many people left on the planet — which Kak noted was just over the population of the UK — great metropolises such as London and New York will quickly turn into ghost towns, according to the professor. 3 Passengers on the London Eye watch the London skyline as smoke is seen in the distance on Dec. 11, 2005. Getty Images Advertisement 'I have all the data in the book. This is not just my personal opinion,' said the computer scientist, who claims this population shrinkflation is happening before our eyes. 'People have stopped having babies. Europe, China, Japan, and the most rapid fall in population right now is taking place in Korea,' Kak declared. 'Now, I'm not saying that these trends will continue, but it's very hard to reverse them because a lot of people have children for a variety of reasons.' He added, 'One is, of course, social. In the back of your mind, you have a sense of what the future is going to be like.' Kak invoked the warnings of SpaceX's Elon Musk, who has been quite vocal about plummeting birth rates and population decline and has used it as a rationale for colonizing Mars. 'That's why Musk is saying maybe humans should go to space, maybe build colonies elsewhere, so that should such a tragedy hit Earth, then it could be reseeded,' said Kak. And while he's not sure whether humanity will go extinct, he said that 'what is absolutely certain is that there is a population collapse occurring right before our eyes.'
